Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Mesenchymal Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT06524778
What this trial is testing

Single High-dose Brachytherapy for Giant Osteosarcoma Masses

Who this might be right for
Osteosarcoma
Shanghai Jiao Tong University Affiliated Sixth People's Hospital 16
Not applicableStudy completedNCT00003404
What this trial is testing

Radiation Therapy After Surgery in Treating Women With Phyllodes Tumor of the Breast

Who this might be right for
Breast Cancer
Dartmouth-Hitchcock Medical Center 46
Testing effectiveness (Phase 2)Ended earlyNCT03641326
What this trial is testing

Sunitinib in Sarcomas of the Central Nervous System

Who this might be right for
GliosarcomaCentral Nervous System Sarcoma
National Cancer Institute (NCI) 5
Testing effectiveness (Phase 2)Study completedNCT00061659
What this trial is testing

Study Evaluating the Safety and Efficacy of ABT-510 in Subjects With Locally Advanced or Metastatic Soft Tissue Sarcoma

Who this might be right for
Sarcoma, Soft Tissue
Abbott 88
Testing effectiveness (Phase 2)Study completedNCT00400569
What this trial is testing

Phase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue Sarcoma

Who this might be right for
LiposarcomaLeiomyosarcomaFibrosarcoma+1 more
H. Lee Moffitt Cancer Center and Research Institute 48
Testing effectiveness (Phase 2)Study completedNCT00041808
What this trial is testing

Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver

Who this might be right for
Metastases, NeoplasmColorectal NeoplasmsEsophageal Neoplasms+9 more
FeRx 20
Post-approval studies (Phase 4)UnknownNCT00339118
What this trial is testing

EpSSG (European Soft Tissue Sarcoma Study Group) Protocol for Non-Metastatic Rhabdomyosarcoma in Children

Who this might be right for
Rhabdomyosarcoma
Sheba Medical Center
Early research (Phase 1)Study completedNCT00000769
What this trial is testing

A Phase I/II Study of Recombinant Interleukin-4 in AIDS and Kaposi's Sarcoma

Who this might be right for
Sarcoma, KaposiHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 48
Testing effectiveness (Phase 2)Study completedNCT03190174
What this trial is testing

Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers

Who this might be right for
Ewing SarcomaPEComaEpithelioid Sarcoma+11 more
Sarcoma Oncology Research Center, LLC 34
Testing effectiveness (Phase 2)Looking for participantsNCT06541262
What this trial is testing

Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

Who this might be right for
NeuroblastomaEwing SarcomaOsteosarcoma+2 more
Milton S. Hershey Medical Center 104
Testing effectiveness (Phase 2)UnknownNCT00025103
What this trial is testing

Chemotherapy Followed by Surgery and Radiation Therapy With or Without Stem Cell Transplant in Treating Patients With Relapsed or Refractory Wilms' Tumor or Clear Cell Sarcoma of the Kidney

Who this might be right for
Kidney Cancer
Children's Cancer and Leukaemia Group 75
Testing effectiveness (Phase 2)UnknownNCT04012827
What this trial is testing

Apatinib Mesylate Combined With Doxorubicin and Ifosfamide in Advanced Soft-tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
Sun Yat-sen University 108
Not applicableLooking for participantsNCT06805669
What this trial is testing

This is a Randomized Study of Early Involvement of Palliative Care Along Side Standard Treatment Versus Standard Treatment Alone in Newly Diagnosed Patients With Advanced or Metastatic Soft Tissue Sarcoma (SARQUALITY)

Who this might be right for
Sarcoma
Mount Sinai Hospital, Canada 136
Not applicableStudy completedNCT03860376
What this trial is testing

Ex Vivo Drug Sensitivity Testing and Mutation Profiling

Who this might be right for
Recurrent Childhood Acute Myeloid LeukemiaRecurrent Childhood Acute Lymphoblastic LeukemiaRecurrent Childhood Large Cell Lymphoma+11 more
Florida International University 25
Early research (Phase 1)Study completedNCT03283696
What this trial is testing

Olaratumab (LY3012207), Doxorubicin, and Ifosfamide in Participants With Advanced or Metastatic Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
Eli Lilly and Company 24
Testing effectiveness (Phase 2)Study completedNCT00267046
What this trial is testing

Evaluate PKs and Efficacy Assessment of Palifermin in Patients With Sarcoma

Who this might be right for
SarcomaOral Mucositis
M.D. Anderson Cancer Center 49
Not applicableLooking for participantsNCT05653388
What this trial is testing

Metastatic Leiomyosarcoma Biomarker Protocol

Who this might be right for
Leiomyosarcoma
University of Michigan Rogel Cancer Center 200
Not applicableLooking for participantsNCT06898203
What this trial is testing

Precision Imaging to Evaluate Kaposi Sarcoma

Who this might be right for
Kaposi Sarcoma
Washington University School of Medicine 180
Testing effectiveness (Phase 2)Study completedNCT04794127
What this trial is testing

Study on Trabectedin in Combination With Pioglitazone in Patients Myxoid Liposarcomas With Stable Disease After T Alone.

Who this might be right for
Liposarcoma, MyxoidLiposarcoma, DedifferentiatedLiposarcoma, Round Cell
Mario Negri Institute for Pharmacological Research 10
Early research (Phase 1)Looking for participantsNCT05400603
What this trial is testing

Allogeneic Expanded Gamma Delta T Cells With GD2 Chemoimmunotherapy in Relapsed /Refractory Neuroblastoma or Refractory/ Relapsed Osteosarcoma

Who this might be right for
NeuroblastomaRefractory NeuroblastomaRelapsed Neuroblastoma+2 more
Emory University 24
Next Page